R Laucirica Selected Research

des-(1-3)- insulin-like growth factor 1

2/2000

Cooperative interaction between mutant p53 and des(1-3)IGF-I accelerates mammary tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Laucirica Research Topics

Disease

4	Neoplasms (Cancer) 01/2001 - 02/2000
2	Carcinoma (Carcinomatosis) 11/2001 - 01/2001
2	Breast Neoplasms (Breast Cancer) 11/2001 - 01/2001
2	Hyperplasia 01/2001 - 02/2000
2	Carcinogenesis 02/2000 - 02/2000
1	Transitional Cell Carcinoma 11/2000
1	Carcinoma in Situ 11/2000
1	Adenocarcinoma 02/2000
1	Tetraploidy 02/2000

Drug/Important Bio-Agent (IBA)

1	MIB-1 antibodyIBA 11/2001
1	Estrogen Receptor betaIBA 01/2001
1	Formaldehyde (Formol)FDA Link 01/2001
1	ParaffinIBA 01/2001
1	Tamoxifen FDA LinkGeneric 01/2001
1	Protein Isoforms (Isoforms)IBA 01/2001
1	CCAAT-Enhancer-Binding Protein-betaIBA 01/2001
1	Estrogen Receptor alphaIBA 01/2001
1	AntibodiesIBA 11/2000
1	Tumor Viral Antigens (Large T Antigen)IBA 02/2000
1	Estrogens (Estrogen)FDA Link 02/2000
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 02/2000
1	GlucocorticoidsIBA 02/2000
1	DNA (Deoxyribonucleic Acid)IBA 02/2000
1	Proteins (Proteins, Gene)FDA Link 02/2000
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2000
1	des-(1-3)- insulin-like growth factor 1IBA 02/2000

Therapy/Procedure

3	Therapeutics 01/2001 - 02/2000
1	Adjuvant Chemotherapy 11/2001
1	Cystectomy 11/2000